Well the annual shareholders meeting is on Wednesday, and I put in my proxy vote, not that it matters... I wonder if we will get any material news next week, or just same old generic meeting? I'm going to try to listen in, but not sure of my schedule.
A few questions I would like to ask are:
1. The current accuracy of the device can detect THC down to 10ng/ml, have you made improvements, and what is the end point goal in terms of accuracy?
2. You previously stated you had begun human trials, and had a framework in place to begin Beta testing of the saliva based system. Where do you currently stand as far as this Beta testing, has it begun? Any insight here?
3. In regard to marketing, and brand awareness, Lifeloc seems to be very complacent with their achievements thus far, and the share price suffers due to this. Do you have a plan in place to increase marketing, social media awareness, and attract investors ?
4. Do you still feel that you are on track to begin commercialization of the saliva based, SpinDx device next year, and if so, do you have an expected timeline to integrate this system with the LX9 Breathalyzer.
5. Do you feel that you have sufficient means to continue funding the development of this device organically, without the need to raise cash through borrowing or Equity financing?
6. What do you value the Saliva based SpinDx device at in terms of yearly sales forecasts after commercialization? What price point do you expect to come in at for the device, and any associated hardware/software. What is an estimated price of the consumable disks, and will these be manufactured by Lifeloc, or a third party.
7. Do you expect that this device will meet the requirements of most modern registration standards set in place by the US, and abroad?
Investors have been patient for many years now, going all the way back to 2014, when Lifeloc was awarded a $250,000 grant by the state of Colorado, to develop a marijuana breathalyzer. An investment in Lifeloc common stock in 2014 would be worth half now, at best, and probably much less. Lifeloc's Market Cap is currently much lower than it's peers competing in the same market. It's time to bring this company, it's common stock, and it's investors to the forefront.
